Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05179538 · ClinicalTrials.gov registry record · NA
Genetic and Cognitive Predictors of Aphasia Treatment Response
A NA study of Aphasia, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05179538 is a NA study of Aphasia that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 120 participants, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05179538, a NA study of Aphasia, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Aphasia, or language impairment after a stroke, affects approximately 2 million people in the United States, with an estimated 180,000 new cases each year. The medical community cannot predict how well someone with aphasia will respond to treatment, as some people with aphasia are poor responders to intervention even when participating in empirically supported treatments. There is a strong likelihood that genetics play a role in language recovery after stroke, but very little research has been dedicated to investigating this link. This study will investigate whether two genes and cognitive abilities, such as memory, predict responsiveness to aphasia therapy for word-retrieval difficulties.
Conditions Studied
Interventions
- BEHAVIORAL Cued picture-naming therapy
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-10-23 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05179538
The ClinicalTrials.gov registry entry for NCT05179538 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 42 other Aphasia trials with a reported enrollment target (48% higher). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Cued picture-naming therapy is the first listed.
NCT05179538 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05179538 about?
NCT05179538 is a clinical study titled "Genetic and Cognitive Predictors of Aphasia Treatment Response". Aphasia, or language impairment after a stroke, affects approximately 2 million people in the United States, with an estimated 180,000 new cases each year. The medical community cannot predict how well someone with aphasia will respond to treatment, as some people with aphasia are poor responders to...
What is the current status of trial NCT05179538?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2020-10-23. Estimated completion is 2026-05.
What conditions does trial NCT05179538 study?
This clinical trial studies the following conditions: Aphasia.
What interventions are being tested in trial NCT05179538?
The interventions under investigation include: Cued picture-naming therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05179538?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05179538 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.